会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Composition and method for the restoration and preservation of transplant organs procured from DCD donors
    • 从DCD供体采购的移植器官的恢复和保存的组成和方法
    • US08802361B2
    • 2014-08-12
    • US13155608
    • 2011-06-08
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • A01N1/00
    • A01N1/02A01N1/0226
    • The present invention provides a perfusion solution comprising specific metabolic agents, antioxidant agents, and membrane stabilizer agents that can help improve preservation, organ viability, and in some cases recover organs that would otherwise being unusable for transplantation. In a further embodiment, the perfusion solution can be used in combination with hypothermic machine perfusion. It has been found that combination of the perfusion solution and hypothermic machine perfusion can help prevent or reduce further damage to the organ and restore the organ's anti-oxidant system, stabilize the cellular cytoskeleton and cellular membranes, inhibit arachidonic acid pathway, provide oncotic support, reduce interstitial edema formation, and help restore energy stores within the organ. As a result, the method can be used to improve the viability of otherwise marginal donor organs.
    • 本发明提供了包含特异性代谢剂,抗氧化剂和膜稳定剂的灌注溶液,所述代谢剂,抗氧化剂和膜稳定剂可以帮助改善保存,器官活力,并且在某些情况下可以回收否则不能用于移植的器官。 在另一个实施方案中,灌注溶液可以与低温机器灌注组合使用。 已经发现灌注溶液和低温机器灌注的组合可以有助于预防或减少对器官的进一步损伤并恢复器官的抗氧化系统,稳定细胞细胞骨架和细胞膜,抑制花生四烯酸途径,提供花药支持, 减少间质性水肿形成,并帮助恢复器官内的能量储存。 因此,该方法可用于改善否则边缘供体器官的生存力。
    • 2. 发明申请
    • Composition and Method for the Restoration and Preservation of Transplant Organs Procured From DCD Donors
    • 从DCD捐赠者采购的移植器官的恢复和保存的组成和方法
    • US20110236875A1
    • 2011-09-29
    • US13155608
    • 2011-06-08
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • A01N1/02
    • A01N1/02A01N1/0226
    • The present invention provides a perfusion solution comprising specific metabolic agents, antioxidant agents, and membrane stabilizer agents that can help improve preservation, organ viability, and in some cases recover organs that would otherwise being unusable for transplantation. In a further embodiment, the perfusion solution can be used in combination with hypothermic machine perfusion. It has been found that combination of the perfusion solution and hypothermic machine perfusion can help prevent or reduce further damage to the organ and restore the organ's anti-oxidant system, stabilize the cellular cytoskeleton and cellular membranes, inhibit arachidonic acid pathway, provide oncotic support, reduce interstitial edema formation, and help restore energy stores within the organ. As a result, the method can be used to improve the viability of otherwise marginal donor organs.
    • 本发明提供了包含特异性代谢剂,抗氧化剂和膜稳定剂的灌注溶液,所述代谢剂,抗氧化剂和膜稳定剂可以帮助改善保存,器官活力,并且在某些情况下可以回收否则不能用于移植的器官。 在另一个实施方案中,灌注溶液可以与低温机器灌注组合使用。 已经发现灌注溶液和低温机器灌注的组合可以有助于预防或减少对器官的进一步损伤并恢复器官的抗氧化系统,稳定细胞细胞骨架和细胞膜,抑制花生四烯酸途径,提供花药支持, 减少间质性水肿形成,并帮助恢复器官内的能量储存。 因此,该方法可用于改善否则边缘供体器官的生存力。
    • 3. 发明授权
    • Composition and method for the restoration and preservation of transplant organs procured from DCD donors
    • 从DCD供体采购的移植器官的恢复和保存的组成和方法
    • US07977042B2
    • 2011-07-12
    • US11460261
    • 2006-07-27
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • Charles Y. LeeMark G. ClemensJian X. ZhangShailendra Jain
    • A01N1/00
    • A01N1/02A01N1/0226
    • The present invention provides a perfusion solution comprising specific metabolic agents, antioxidant agents, and membrane stabilizer agents that can help improve preservation, organ viability, and in some cases recover organs that would otherwise being unusable for transplantation. In a further embodiment, the perfusion solution can be used in combination with hypothermic machine perfusion. It has been found that combination of the perfusion solution and hypothermic machine perfusion can help prevent or reduce further damage to the organ and restore the organ's anti-oxidant system, stabilize the cellular cytoskeleton and cellular membranes, inhibit arachidonic acid pathway, provide oncotic support, reduce interstitial edema formation, and help restore energy stores within the organ. As a result, the method can be used to improve the viability of otherwise marginal donor organs.
    • 本发明提供了包含特异性代谢剂,抗氧化剂和膜稳定剂的灌注溶液,所述代谢剂,抗氧化剂和膜稳定剂可以帮助改善保存,器官活力,并且在某些情况下可以回收否则不能用于移植的器官。 在另一个实施方案中,灌注溶液可以与低温机器灌注组合使用。 已经发现灌注溶液和低温机器灌注的组合可以有助于预防或减少对器官的进一步损伤并恢复器官的抗氧化系统,稳定细胞细胞骨架和细胞膜,抑制花生四烯酸途径,提供花药支持, 减少间质性水肿形成,并帮助恢复器官内的能量储存。 因此,该方法可用于改善否则边缘供体器官的生存力。